Hydrocortisone Administration and Blood Sugar Control in Septic Shock
Author Information
Author(s): Loisa Pekka, Parviainen Ilkka, Tenhunen Jyrki, Hovilehto Seppo, Ruokonen Esko
Primary Institution: Päijät-Häme Central Hospital
Hypothesis
Continuous hydrocortisone infusion would reduce the occurrence of hyperglycemic and hypoglycemic episodes when compared to conventional bolus treatment.
Conclusion
Strict normoglycemia is more easily achieved if the hydrocortisone therapy is given to septic shock patients by continuous infusion.
Supporting Evidence
- The mean blood glucose levels were similar in both groups.
- The bolus group had significantly more hyperglycemic episodes than the infusion group.
- More adjustments in insulin infusion rates were needed in the bolus group.
Takeaway
Giving hydrocortisone continuously helps keep blood sugar levels steady in patients with septic shock, making it easier for doctors to manage their care.
Methodology
This was a prospective randomized study comparing blood glucose profiles and insulin requirements in 48 septic shock patients receiving hydrocortisone by bolus or continuous infusion.
Potential Biases
Potential bias due to lack of blinding and variability in nutritional support.
Limitations
The study was not placebo-controlled or blinded, and nutritional support varied among patients.
Participant Demographics
Patients with septic shock, excluding those under 18, with pre-existing diabetes, or receiving glucocorticoids.
Statistical Information
P-Value
0.039
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website